CIEN vs NVDA

Ciena Corporation exhibits a stable financial health profile with a Piotroski F-Score of 4/9, but is currently experiencing a severe valuation decoupling. The current price of $520.80 is astronomically higher than both the Graham Number ($26.32) and the growth-based Intrinsic Value ($46.02). While the company shows explosive earnings growth and strong liquidity, the P/E ratio of 333.85 and a bearish technical trend (10/100) suggest the stock is in a speculative bubble. Furthermore, the current price sits significantly above the analyst target mean of $378.11, indicating substantial downside risk.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.